 BOTHELL, Wash. , Jan. 17, 2023 PRNewswire -- BioLife Solutions, Inc. Nasdaq: BLFS BioLife or the Company, a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy CGT and the broader biopharma markets, today announced the dates of its 2023 analyst day and upcoming investor conferences where management will be presenting and meeting with current and prospective investors. 